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Summary Epidemiological studies suggest that childhood common acute lymphoblastic leukaemia (c-ALL)
may be the rare outcome ofearly post-natal infection with a common infectious agent. One of the factors that
may determine whether a child succumbs to c-ALL is how it responds to the candidate infection. Since immune
responses to infection are under the partial control of (human leucocyte antigen) HLA genes, an association
between an HLA allele and c-ALL could provide support for an infectious aetiology. To define the limit of c-
ALL susceptibility within the HLA region, we have compared HLA-DQBI allele frequencies in a cohort of 62
children with c-ALL with 76 newborn controls, using group-specific polymerase chain reaction (PCR)
amplification, and single-strand conformation polymorphism (SSCP) analysis. We find that a significant excess
of children with c-ALL type for DQBI*05 [relative risk (RR): 2.54, uncorrected P=0.038], and a marginal
excess with DQBI*0501 (RR: 2.18; P=0.095). Only 3 of the 62 children with c-ALL have the other
susceptibility allele, DPBI*0201 as well as DQBI*0501, whereas 15 had one or the other allele. This suggests
that HLA-associated susceptibility may be determined independently by at least two loci, and is not due to
linkage disequilibrium. The combined relative risk of the two groups of children with DPBI*0201 and/or
DQBI*0501 is 2.76 (P=0.0076). Analysis of amino acids encoded by exon 2 of DQBI reveal additional
complexity, with significant (P<0.05) or borderline-significant increases in Gly26, His30, Val57, Glu66-Val67
encoding motifs in c-ALL compared with controls. Since these amino acids are not restricted to DQBI*0501,
our results suggest that, as with DPBI, the increased risk of c-ALL associated with DQBI is determined by
specific amino acid encoding motifs rather than by an individual allele. These results also suggest that HLA-
associated susceptibility to c-ALL may not be restricted to the region bounded by DPBI and DQBI.
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Childhood acute lymphoblastic leukaemia (ALL) is the most
frequently occurring leukaemia among children of the
developed countries (Breslow and Langholz, 1983; Parkin et
al., 1988; Linet and Devesa, 1991). A unique feature of ALL
in white Caucasian children is the peak number of cases that
occurs between the ages of 2 and 5 years (Stewart, 1961;
Parkin et al., 1988; Linet and Devesa, 1991). This first
appeared in the UK as a mortality peak after 1920 (Court
Brown and Doll, 1961), and has remained to the present as
an incidence peak, despite a marked reduction in mortality in
the past 3 decades. Immunophenotyping has shown that this
early peak is almost entirely due to the B-cell precursor form
of common ALL (c-ALL) (Greaves, Pegram and Chan,
1985). Suggestions that the c-ALL peak was unmasked
following a decline in pre-emptive childhood mortality from
infectious disease between the early 1900s and 1940 (Stewart
and Kneale, 1969; Kneale, 1971) have been questioned by
Greaves et al. (1991) on the grounds that no similar increase
in other subtypes of childhood acute leukaemia has been
seen.
The role of infection in the aetiology of childhood ALL
has recently been re-examined in relation to its cell biology,
the timing of post-natal infection (Greaves and Alexander,
1993) and population mixing (Kinlen et al., 1990), and has
suggested that childhood c-ALL may be the rare outcome of
a common but unidentified neonatal infection. This poses
questions about the contribution of potentially rate-limiting
host factors such as genetic susceptibility (Taylor, 1994). In
order to determine whether these could involve immune
response genes, we previously analysed the frequency of
HLA-DPBI alleles in c-ALL, and found an increased risk in
children with HLA-DPBI*0201 [relative risk (RR) 2.1-2.9]
(Taylor et al., 1995).
To try to define the physical limit of genetic susceptibility
within the HLA region, we have now typed the same cohort
of children for alleles at the HLA-DQBI locus. This is a
related HLA class II gene approximately 420 kb telomeric to
DPBI (Trowsdale and Campbell, 1992). DQBI alleles are
associated with susceptibility and resistance to several
malignant and non-malignant diseases notably adult T-ALL
(Uno et al., 1988), cervical intraepithelial neoplasia and
human papilloma virus (HPV) (Apple et al., 1994), type 1
(insulin-dependent) dibetes mellitus (Todd, Bell and McDe-
vitt, 1987) and melanoma (Lee et al., 1994). We report that
children who have DQBI*0501 are at increased risk of c-
ALL, and that this does not appear to be in linkage
disequilibrium with DPBJ*0201. We also find that as with
DPBI, the increased risk associated with DQBI is strongest
in relation to key amino acid motifs rather than with
individual alleles.
Materials and methods
Patients and controls
The patients in this study comprise the same cohort as that
described previously (Taylor et al., 1995) and consists of 62
children (one child from the previous study is excluded) with
c-ALL treated at a single centre (Royal Manchester
Children's Hospital) in the north west of England, between
1990 and 1992. To reduce bias to an absolute minimum, only
children in whom a diagnosis of c-ALL was confirmed by
cytology and immunophenotyping according to the Medical
Research Council's 11th ALL trial (UKALL XI) guidelines
are included in the analysis. Patients with other leukaemia
Correspondence: GM Taylor, Immunogenetics Laboratory, St Marys
Hospital, Hathersage Road, Manchester, M13 OJH, UK
Received 30 June 1995; revised 11 September 1995; accepted 22
September 1995HLA-QBl m din
- -d c-ML.
SP Dearden et i
subtypes. including those with unclassified ALL are excluded.
Blood samples were obtained from children, usually in
remission, either in the clinic or at home with parental
consent. The blood was anticoagulated with EDTA, and
frozen before DNA extraction within 12 h of donation.
Control blood samples were obtained from the placental side
of the clamped umbilical cord of normal full-term babies
delivered at St Mary's Hospital. Preterm deliveries, caesarean
sections and pregnancies with complications were excluded.
DNA extraction and amplification
Genomic DNA was extracted from fresh or frozen blood
samples using established methods (Blin and Stafford, 1976),
and an exon 2 fragment ofDQB1 amplified in the polymerase
chain reaction (PCR; Erlich and Arnheim, 1992) using the
oligonucleotide primers depicted in Table I and Figure 1.
These DQBJ locus-specific primers do not amplify the related
but non-expressed DQB2 or DQB3 genes. The primers were
designed to amplify four groups of alleles (nomenclature
according to WHO guidelines): the *021*03 group (0201,
0301, 0302, 0303, 0304), the *04 group (0401, 0402), the *05
group (0501, 0502, 0503, 0504) and the *06 group (0601,
0602, 0603, 0604, 0605, 0606, 0607, 0608).
DQBI amplifications were carried out in mixtures
consisting of 50 ng genomic DNA, 2 pl 10 x PCR buffer
(500 mm potassium chloride, 100 mM Tris-HCI, pH 8.8, 1%
Triton X-100), 2 p1 2.5 mM primer mix, 3 p1 2 mM dNTP
mixture, 2.4 p1 25 mM magnesium chloride, 0.5U Taq DNA
polymerase (Promega, Madison WI, USA), and sterile
distilled water to 20 p1. Reaction mixtures were overlaid
with 20 p1 of Chill-Out liquid wax (MJ Research, Watertown,
MA, USA) to prevent refluxcing, and consisted of an initial
denaturation step (94CC, 150 s) followed by 36 cycles of
denaturation (94^C, 45 s) annealing/extension (58CC, 45 s)
and a final extension step (74CC, 180 s), using a thermal
cycler (Crocodile II, Appligene. France). The reaction
products were monitored by electrophoresis on 0.8%
agarose minigels.
Single-strand conformation polvmorphism (SSCP) typing
DQBI alleles were detected using the SSCP method described
by Orita et al. (1989), modified for HLA-DQBI typing as
described by Lo et al. (1992) and Summers et al. (1992). For
this, 15 p1 of each PCR product was mixed with 2 p1 of
loading dye (0.5% bromophenol blue, 0.5% xylene cyanol in
deionised formamide), and heated to 95CC for 10 min to
Table I Sequences of DQB1 primers
Frag-
Prinera Sequence Codonb ment AlleleSb
(bp)
02'03 group
P3a ACGGAGCGCGTGCGTTA 26 210 0301
P3b ACGGAGCGCGTGCGTCT 26 210 0201/0302/
0303
P3R CAAGGTCGTGCGGAGCT 86
04 group
P4a TCCCGAGGATTTCGTGTT 9 235 0401 0402
P4b ACCAACGGGACCGAGCT 23 195 0402
P4R GTTGTGTCTGCATACGG 77
05 group
P5 GGAGCGCGTGCGGGG 26 206 All 05s
P5R GGATCCCGCGGTACGC 86
06 group
P3a As above 204 0601
P3b As above 204 0602,0603,
0604
P6S CCCGCGGAACGCCACCTC 84
aP3a, P3b,P4a, P4b, P5 are sense primers;P3R, P4R, P5R, P6S are
an e primers. bCodon number is the 3' end ofeach primer.
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Fugwe 1 Schematic representation of DQBJ exon 2 showing the
positions of primers used for group-specific PCR amplification
(P3a, P3b etc.), and the size of PCR products produced. Primer
sequences are shown in Table I.
denature the DNA and reduce the sample volume to 4-5 p1.
The samples were loaded onto non-denaturing polyacryla-
mide gels (PAGs) in a water-cooled vertical mimn-electro-
phoresis unit (Cambridge Electrophoresis, Cambridge, UK).
SSCP conditions for all group-specific PCR products were
the same, including the ratio of acrylamide-methylbisacry-
lamide (39:1), which was prepared from stock Easigel mix
(Scotlab, Strathclyde, UK) and solid acrylamide (BDH,
Lutterworth, UK). SSCP gels were run using 0.5X TBE
and 0.8 mm spacers, at 9 mA constant current. SSCP band
patterns were visualised using silver staining (Qiagen,
Dusseldorf, Germany) following the manufacturer's instruc-
tions and photographed using a 35 mm SLR camera without
filters and Agfa Ortho film.
Data analysis
DQBI allele frequencies in c-ALLs and controls were
calculated as percentages of total alleles. Phenotype
frequencies were determined as the percentage of test
subjects with a given allele in either heterozygous or
homozygous form. Genotype frequencies were obtained by
calculating the proportion of individuals with combinations
of two alleles. Relative risks (RRs) were obtained by the
cross-product odds ratio method, and these were tested for
significance using 2 x 2 (x2) contingency analysis using
SIMFIT. Since this study was used for hypothesis genera-
tion, no correction for the number of alleles tested has been
applied.
Resuls
DQB1 molecular typing
In preliminary studies to optimise DQBI molecular typing,
we used generic primers obtained from the British Society for
Histocompatibility and Immunogenetics (BSHI) to amplify
exon 2 from genomic template DNA, and BSHI-derived
sequence specific oligonucleotide (SSO) probes to detect
specific alleles. However, in our hands, we were unable to
distinguish certain DQBI alleles using this system. We
therefore designed a set of nine primers as shown in Table
I and Figure 1, which we used in various combinations to
amplify groups of alleles, and SSCP analysis to distinguish
the alleles within each group. Using this method we were also
able to confirm and clarify DQBI allele assignments obtained
on HLA homozygous and heterozygous test cells typed with
genenc prmers and SSO probes. All pairs of group-specific
primers were found to amplify in the predicted manner
according to Table I. No amplification ofother allelic groups
was obtained, and it was not necessary to introduce
deliberate mismatches into the primer sequences to improve
speficity.
The results in Figure 2 show SSCP band patterns obtained
with the DQBI 02/03 group-specific primers on homozygous
and heterozygous cells. They are distinct enough to allow
alleles to be assigned in heterozygotes. No DNA was
available for the following rare alleles: DQB1*0304, *0605-
*0608, but these alleles would have been amplified by our
group-specific primers and may give distinct bands.
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Figure 2 Representative SSCP PAG gel showing silver-stained band patterns obtained after amplification with *02/*03 group-
specific primers. Other alleles were assigned following PCR-SSCP analysis with other primers.
Table II HLA-DQBJ allele and phenotype frequency in childhood c-ALL and infant controls
Allele frequency (%) Phenotypefrequency (%) Phenotype analysis
Allele c-ALL Infants c-ALL Infants RR x2 P value
*0201 24.2 37.5 43.5 55.3 0.62 1.43 0.23
*0301 17.7 15.8 30.6 25.0 1.33 0.29 0.58
*0302 4.8 7.9 9.7 13.2 0.71 0.13 0.71
*0303 2.4 7.2 4.8 13.2 0.34 1.88 0.17
*0401 0.0 0.0 0.0 0.0 _ _ _
*0402 2.4 0.7 4.8 1.3 3.81 0.51 0.47
*0501 16.9 9.2 29.Oa 15.8a 2.18b 2.78 0.09a
*0502 0.8 0.0 1.6 0.0 - - -
*0503 0.8 0.0 1.6 0.0 -
*0504 0.0 0.0 0.0 0.0 - - -
*0601 6.5 3.3 12.9 6.6 2.1 0.94 0.33
*0602 12.9 12.5 19.4 18.4 1.06 0.006 0.93
*0603 6.5 4.0 12.9 6.6 2.1 0.94 0.33
*0604 4.0 2.0 8.1 2.6 3.25 1.11 0.29
n 124 152 62 76
aPhenotype frequencies in which there is a significant difference between c-ALLs and controls. bRelative risk (RR)
for which there is borderline significance between c-ALL and controls. *P-value.
DQB1 allele frequency in childhood c-ALL
Details of the children with c-ALL who were typed for DQBJ
in this study are given in a previous paper (Taylor et al.,
1995). Briefly, 62 children with a confirmed diagnosis of c-
ALL, consisting of 36 boys and 26 girls (M/F 1.42:1) with a
mean age of 5.6 years and age range of 1 - 13 years
constituted the patient cohort. About one-third of the girls,
but nearly half of the boys were diagnosed at 3-4 years of
age. Eight of the 62 children with c-ALL were from ethnic
minorities, mainly of Asian origin. The present cohort of c-
ALLs comprises 83% of children with ALL ascertained by
the Manchester Children's Tumour Registry during the study
period. The remainder of the ALLs were excluded from the
analysis as being other subtypes, or not confirmed as c-ALL.
The control series used here consists ofcord blood samples
from 76 Caucasian newborn infants delivered in St Mary's
between 1990 and 1992. The only subjects excluded from this
cohort were preterm and caesarean deliveries and congenital
abnormalities. A total of 14 DQBI alleles were identified by
SSCP typing of the patient and control groups and of these,
12 alleles were detected in the c-ALLs and ten in the controls.
Alleles missing both from patients and controls included
*0401 and *0504, whereas *0502 and *0503 were absent from
the control series only. A comparison of allele frequencies
(Table II) shows a deficit ofDQBI*0201 in c-ALLs compared
with the controls (c-ALL, 24.2% vs controls, 37.5%), but an
excess of *0501 in c-ALLs (c-ALLs, 16.9% vs controls,
9.2%). There is no difference in *0602 frequency in c-ALL
and controls, but there is an excess of the combined *0601,
*0603 and *0604 alleles in c-ALLs (c-ALLs, 17% vs controls,
9.3%). In addition, the combined frequency of *0302 and
*0303 in c-ALL is about half that in the controls (c-ALLs,
7.2% vs controls, 15.1%).
The deficit of *0201 and excess of *0501 alleles in c-ALL is
seen more informatively in the phenotype frequency analysis
(Table II), which compares the frequency of patients and
controls who carry specific alleles. There is a deficit of 11.8%
of children with c-ALL who have DQBI*0201, compared
with infant controls (c-ALLs vs infants, 43.5% vs 55.3%),
although this is not significant. However, 13.2% more
children with c-ALLs have *0501 (c-ALLs vs infants, 29%
vs 15.8%), and this reaches borderline significance. Moreover
if we combine phenotype frequencies of all *05 series alleles
(*0501, *0502, *0503), the cumulative RR (2.54) is significant
(P=0.038). In addition, cumulative phenotype frequencies
indicate that over twice as many children with c-ALL type
for *0601, *0603 or *0604 (c-ALLs vs infants, 33.9% vs
15.8%), and nearly half as many type for *0302 and *0303
(14.5% vs 26.4%).
Since there are nearly 50% more boys than girls in our
c-ALL cohort, we examined whether there might be aHLA-DQB1 in childhood c-ALL
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Table III HLA-DQBI allele and phenotype frequencies in girls and boys with c-ALL
Allele frequency (%) Phenotype frequency (%) Phenotype analysis
Allele Females Males Females Males RR X2 P value
*0201 25.0 (12) 23.7 (18) 45.8 42.1 0.86 6.4x 104 0.97
*0301 20.8 (10) 15.8 (12) 41.7 26.3 0.50 0.96 0.32
*0302 4.2 (2) 5.3 (4) 8.3 10.5 1.29 0.024 0.87
*0303 2.1 (1) 2.6 (2) 4.2 5.3 1.28 0.169 0.68
*0402 2.1 (1) 2.6 (2) 4.2 5.3 1.28 0.169 0.68
*0501 10.4 (5) 21.1 (16) 16.7a 36.8a 2.92b 2.01 0.15*
*0502 0.0 (0) 1.3 (1) 0.0 2.6 - - -
*0503 0.0 (0) 1.3 (1) 0.0 2.6 - - -
*0601 6.3 (3) 6.6 (5) 12.5 13.2 1.06 0.098 0.75
*0602 20.8 (10) 7.9 (6) 33-3a 10.5a 0.24 3.55 0.05*
*0603 6.3 (3) 6.6 (5) 12.5 13.2 1.06 0.098 0.753
*0604 2.1 (1) 5.3 (4) 4.2 10.5 2.71 0.174 0.676
n 48 76 24 38
aDQBI phenotypes in which there is > 10% difference in frequency in females compared with males. bRelative risks
for alleles showing an increased or decreased frequency in c-ALL. *P-value.
difference in DQBI allele and phenotype frequencies when the
sexes were compared. Table III shows that the frequency of
boys who type for *0501 is over twice that of girls (boys,
36.8% vs girls, 16.7%, RR, 2.92), whereas the frequency of
girls who type for *0602 is over three times that of boys
(girls, 33.3% vs boys, 10.5%, RR, 0.24, P=0.05).
Genotype frequencies in c-ALLs and infant controls are
compared in Table IV. The most striking difference is the
percentage homozygosity (c-ALL, 19.3% vs infants, 42%,
P=0.0016). This is largely the result of a marked difference
in the frequency of *0201 homozygotes (c-ALL vs infants,
4.8% vs 19.7%). However, the cumulative frequency of non-
*0201 homozygotes is also less in c-ALL than it is in the
controls (c-ALLs, 14.5% vs controls, 22.3%). Cumulative
frequencies of certain heterozygotes, such as *0501/*0201 and
*0501/*0301 show quite marked differences (c-ALL, 16.2% vs
controls, 6.5%).
It is possible that the increased risk of c-ALL associated
with DQBI*0501 could be due to linkage disequilibrium with
DPBI*0201, the allele previously shown to be associated with
an increased risk of c-ALL in the same cohort (Taylor et al.,
1995). When we analysed the frequency of patients with both
alleles, however (Table V) we found that only 3 of the 62
children with c-ALL typed for DPBI*0201 and DQBI*0501,
29 had neither allele and 15 each had either DPBI*0201 or
DQBI*0501. Although there is no significant difference in the
frequency of c-ALLs and controls with both alleles or
DPBI*0201 alone, the increased frequency of c-ALLs with
DQBI*0501 but lacking DPBI*0201 is borderline, and there
is a significant decrease in patients with neither allele
compared with controls. Taking the cumulative frequency
of c-ALLs with one or both candidate susceptibility alleles in
comparison with the controls (c-ALLs, 53% vs controls,
29%), the combined RR is 2.76 (P=0.0076).
The DQBJ phenotype analysis shown in Table II shows
that frequency of c-ALL children with alleles other than
DQBI*0501 is also increased. It is possible that this is owing
to associations with amino acids common to more than one
allele, as we found for DPBJ. We therefore analysed the
DQBJ data by calculating the frequency of selected exon 2
encoded amino acids in the patient and control groups.
Amino acids at seven positions were compared (Table VI), of
which three (positions 26, 30 and 57) consist of 3-4 single
amino acids, and four positions (13- 14, 66-67, 70-71, 86-
87) consist of two amino acids. For alleles we scored all
motifs, but for phenotypes we have again expressed the
results as the percentage of subjects with that motif,
(heterozygotes and homozygotes are counted once). This
means that a person can be heterozygous for a DQBI allele,
but homozygous for an amino acid. Table VI shows that
there are significant or borderline differences between c-ALLs
and infant controls for all positions, with RR values ranging
from 2.36 to 3.80. Taken together the results show increases
in Gly26, His30, Val57 and Glu66-Val67 in c-ALL.
Table IV Genotype frequency analysis in childhood c-ALL
Genotypefrequency (%)
Genotype c-ALL Infant
*0201/*0201 4.8b 19.7b
*0201/*0301 11.3 7.9
*0201/*0302 4.8 1.3
*0201/*0303 0.0 3.9
*0201/*0402 1.6 1.3
*0201/*050la 8. la 3.9a
*0201/*0601 3.2 67.6
*0201/*0602 3.2 6.6
*0201/*0603 3.2 3.9
*0201/*0604 3.2 0.0
*0301/*0301 3.2b 6.6b
*0301/*0302 0.0 2.6
*0301/*0303 1.6 2.6
*0301/*0402 0.0 0.0
*0301/*0501a 8.la 2.6a
*0301/*0601 3.2 0.0
*0301/*0602 1.6 1.3
*0301/*0603 3.2 1.3
*0301/*0604 0.0 0.0
*0302/*0302 0.0b 2.6b
*0302/*0303 1.6 3.9
*0302/*0501 0.0 1.3
*0302/*0602 1.6 1.3
*0302/*0603 1.6 0.0
*0303/*0303 0.0b .3b
*0303/*0501 1.6 1.3
*0402/*0602 1.6 0.0
*0402/*0603 1.6 0.0
*0501/*0501 a 4.8a,b 2.6a.b
*0501/*0503a 1.6a O.oa
*050H/*060la 3.2a O.Oa
*0501/*0602 0.0 2.6
*0501/*0604 1.6 1.3
*0502/*0604 1.6 0.0
*0601/*0602 1.6 0.0
*0601/*0603 1.6 0.0
*0602/*0602 6.5b 6.6b
*0602/*0603 1.6 0.0
*0602/*0604 1.6 0.0
*0603/*0603 0.0b 1.3b
*0604/*0604 0.0b 1.3b
n 62 76
Percent homozygosity 19.3 42
aDQB1*0501 genotypes with an excess ofc-ALLs. bHomozygotes.
Discussion
In our previous study we found that children with HLA -
DPBI*0201 are at about twice the risk of developing
common ALL as normal (Taylor et al., 1995). Since there
is a possibility that the DPBI*0201 is not itself the c-ALL
susceptibility gene, but is in linkage disequilibrium with someHLA-DQB1 in childhood c-ALL
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Table V Comparison of c-ALLs and infant controls with HLA-DPBI*0201 and DQBJ*0501
Study groupa Phenotype analysis
Phenotype c-ALL Infants RR x2 P-value
DPBJ*0201 +DQB1*0501 + 3 (4.8) 3 (4.1) 1.17 0.053 0.817
DPBI*0201+DQB1*0501- 15 (24.1) 10 (13.8) 1.98 1.701 0.192
DPBI*0201-DQB1*0501- 29 (46.7) 51 (70.8) 0.36 7.046 0.007b
DPBJ*0201-DQB1*0501 + 15 (24.1) 8 (11.1) 2.55 3.143 0.076
aNumbers of individuals (% of total) with DPBI and DQBI alleles. bSignificant difference between
c-ALL and infant controls.
Table VI DQBJ amino acid motif frequency in childhood c-ALL
Amino acid Allelefrequency (%) Phenotype frequency (%)C Phenotype analysis
positiona Motijb c-ALL Infants c-ALL Infants RR X2 P-value
13- 14 AM 24.2 19.1 41.9 31.6 1.56 1.17 0.28
GLb 18.5 12.5 30.6c 15.8c 2.36 3.52 0.06d
GM 57.3 71.7 75.8 88.2 0.42 2.82 0.09
26 Gb 21.0 9.2 35.5C 15.8c 2.93 6.12 O.Old
L 54.8 71.7 75.8 88.2 0.42 2.82 0.09
Y 24.2 19.1 41.9 31.6 1.56 1.16 0.27
30 Hb 29.0 15.1 48.4c 23.7c 3.02 8.13 0.004d
S 24.2 37.5 43.5 55.3 0.62 1.43 0.23
Y 46.8 47.4 71.0 65.8 1.27 0.22 0.64
57 A 29.0 44.1 48.4 64.5 0.52 2.98 0.08
D 49.2 44.7 71.0 68.4 1.13 0.02 0.89
S 0.8 0.0 1.6 0.0 - - -
Vb 21.0 11.2 35.5C 17.1c 2.67 5.16 0.023d
66-67 DI 33.1 43.4 56.5 57.9 0.94 <0.01 0.99
EVb 66.9 56.6 90.3c 71.1c 3.80 6.69 0.0O9d
70-71 ED 2.4 0.7 4.8 1.3 3.81 0.51 0.47
GAb 18.5 9.2 30.6c 15.8c 2.36 3.51 0.06d
GT 19.4 16.4 30.6 25.0 1.33 0.29 0.58
RK 24.2 37.5 43.5 55.3 0.62 1.43 0.23
RT 35.5 36.2 58.1 52.6 1.25 0.22 0.64
86-87 AF 25.8 19.7 40.3 31.6 1.46 0.79 0.37
AYb 18.5 9.2 30.6c l5.8c 2.36 3.51 0.06d
EL 51.6 69.1 74.2 84.2 0.54 1.54 0.21
GY 4.0 2.0 8.1 2.6 3.25 1.12 0.29
aAmino acid position coded by exon 2. bAmino acid motifs significantly increased in c-ALL. cPhenotypes significantly increased in c-ALL.
dSignificant difference (P <0.05).
other HLA or non-HLA gene, we carried out further
molecular studies on the same cohort to try to define the
physical limit of susceptibility to c-ALL in the HLA region.
The results reported here show that the risk in children who
type for the DQBJ*05 allele series is similar to that for
DPB1*0201. More importantly, this does not seem to be due
to linkage disequilibrium between DPB1*0201 and
DQBI*0501, since only 3 of the 62 patients typed for both
alleles. Lack of linkage disequilibrium between DPBI*0201
and DQBI*0501 is supported by other studies (Baisch and
Capra, 1993). Whereas it is still possible that a susceptibility
allele linked to these alleles at both loci maps to the DPBI-
DQB1 interval, we suggest that susceptibility is conferred
independently by the two alleles. Moreover, alignment of the
amino acids involved in increased DPBJ susceptibility (Val6,
Asp55, Glu69) does not provide evidence for an overlap with
amino acids involved in DQBI susceptibility.
It is not as easy to distinguish DQBI alleles by generic
PCR amplification and SSO probe hybridisation as it is for
DPBI alleles. For this reason, we designed a series of nine
DQBJ group-specific primers, which were used in various
combinations to amplify four allelic groups (*02/*03, *04,
*05 and *06). In conjunction with SSCP analysis of the
group-specific PCR products we were able to distinguish 14
DQBI alleles in heterozygotes. Five alleles were not detected
in our patient and control series, including *0304, and
*0605 -*0608, although it is unlikely that they would not be
detected by our typing system. DQBI*0304 shares sequences
with primers P3a and P3R, and should therefore be amplified
by them. Since it differs at several polymorphic positions
from other *03 alleles, it should have been resolved by SSCP.
DQBI*0605-*0608 should also amplify with the *06 group-
specific primers, since P3b is homologous to these alleles at
the 5' end. Although there are no sequence data for the 3' end
of these alleles, we would expect them to resemble the other
alleles in the series. The possibility that they may not separate
from the other alleles in the group (*0601 -*0604) by SSCP
would have made little difference to the overall result had
they been present.
A number of molecular typing techniques based on PCR-
mediated amplification have been devised to detect DQBI
alleles. In an early method (Bugawan and Erlich, 1991), a
pair of DQBI generic primers and 16 SSO probes were used
to distinguish 15 DQBI alleles. However, other authors using
this method have favoured a combination of group-specific
amplification and SSO-based typing (Malkentin et al., 1991)
to improve resolution. The exacting conditions required for
SSO probe hybridisation have led to the development of
alternative typing methods, including sequence-specific primer
(SPP)-based amplification (Olerup, Aldener and Fogdell,
1993; Salazar et al., 1993). While this has the benefit of
being both rapid and high resolution, novel alleles within theHLA-DQB1 in childhood c-ALL
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amplified sequence could be missed, and sequence variations
outside this region would go undetected. For disease
association studies, in which time is less important than in
donor-recipient transplant matching, PCR-SSCP using
group-specific amplification combines a low-resolution
PCR-SSP approach, with the sequence-dependent resolving
power of PAG electrophoresis. This approach was first
demonstrated for DQBI by Lo et al. (1992), and the value of
group-specific amplification documented by Carrington et al.
(1992). Although we have used silver staining to assign
alleles, our method should lend itself to more rapid typing
using fluorescent primers in conjunction with an automated
sequencer.
We have not corrected our results for the number of allele
comparisons, so we cannot at present completely rule out
that the DQBI*05 association occurred by chance. The
difficulty of providing conclusive proof of an increased
genetic risk due to DQBI*05 in c-ALL is not one of
ascertainment, because our patients are an unbiased
prospective group from a single geographical region. The
problem concerns the relative rarity of this disease, despite
the fact that childhood c-ALL is itself the commonest
childhood malignancy. At the level of risk found here, we
would have needed at least twice the number of patients to
verify the association. However, our results provide a useful
basis for hypothesis generation and a preliminary answer to
the question of whether the DPBI*0201 association is due to
linkage disequilibrium.
Ifgenetic susceptibility to c-ALL is conferred by DQBI*05
it suggests some degree of specificity in the interaction with
an environmental co-factor. Since there is no evidence from
our studies so far that DPBI or DQBI alleles in childhood c-
ALL are mutated in the germ line, we assume that the
increased risk is conferred by the normal allele itself. This
raises the question as to why a relatively common HLA allele
should increase the risk of a previously lethal childhood
disease such as c-ALL, a clear selective disadvantage to the
allele. We previously suggested in the context of DPBI that
one explanation for this could be that since HLA alleles are
neither necessary nor sufficient to cause leukaemia they may
confer protection to some numerically more important
infectious agent. Thus, c-ALL high-risk HLA alleles might
be less effective in protecting against a leukaemogenic
infection caused by molecular mimicry of the susceptibility
allele by the infectious agent, but be effective against some
other infection. Since the transformation of pre-B progenitor
cells into c-ALL requires at least two mutations, it seems
unlikely that HLA alleles determine whether a fetus will
succumb to an in utero infection. This might be expected to
be associated with birth abnormalities in children with
leukaemia.
A different interpretation is suggested by the Greaves
hypothesis (Greaves and Alexander, 1993). This postulates
that the chance of a second mutation in a preleukaemic pre-B
progenitor population is promoted by post-natal infection-
induced cell division. HLA alleles associated with a risk of c-
ALL might in this case be the target of, or induce, the
immunostimulatory signals which lead to the increased
division of the pre-leukaemic population. If an infectious
agent contained immunogenic peptides capable of binding to
alleles at more than one HLA class II locus, this might
maximise immune recognition but also enhance pre-B
stimulation. Such a phenomenon might explain the apparent
independence of DPBI- and DQBI-associated susceptibility
to c-ALL.
We found a difference in the percentage of boys and girls
with DQBI*0501 (RRM:F, 2.92), and DQB1*0602 (RRM:F,
0.24). This sex difference in the frequency of a susceptibility
allele was absent in our previous analysis of DPBI (Taylor et
al., 1995). One explanation for the sex difference could be
that there are subtle male-female differences in genetic
susceptibility to immune-associated disease as previously
suggested (Purtilo, 1979). Since there is an excess of males
to female with c-ALL in our series, it is possible that X-
linked immunoregulatory genes influence the ability of males
and females to respond to HLA-associated immunogenic
peptides.
Genotype analysis revealed a higher frequency of
DQBI*0201 homozygosity in the controls than in the
patients. We can exclude typing artifact due to the
misidentification of heterozygotes as homozygotes as both
series were typed at the same time, using the same reagents
and techniques. We can also exclude increased HLA
homozygosity due to consanguineous ethnic minority
parents, since we excluded Asian infants from the control
series. The result suggests that *0201 homozygosity may have
a protective effect in c-ALL. It is ofinterest to note that none
of the amino acid sequence motifs found in *0501, or any of
the other alleles associated with an increased risk of c-ALL is
also found in *0201. More specifically, the serine residue at
position 30, and arginine-lysine at positions 70-71 of *0201,
both differ from the motifs associated with DQBI suscept-
ibility to c-ALL, and may be considered as conferring
protection.
The amino-acid motifs associated with an increased risk of
c-ALL include glycine26, histidine30, valine 5 and glutamic
acid66-valine67. Of the four motifs at position 57, aspartic
acid (Asp57) is present in only 48% of children with c-ALL
compared with 64% of infant controls, and is negatively
associated with c-ALL. It has been known for some time that
Asp57 confers resistance to insulin-dependent diabetes (Todd
et al., 1987; Morel et al., 1988; Tosi et al., 1994), although the
presence or absence of this motif is not sufficient to account
for inherited susceptibility (Thomson et al., 1988; Kockum et
al., 1993). Although there are few similarities between c-ALL
and IDDM other than their occurrence in childhood, the
possibility that a common infectious agent, or similar
immunoregulatory defect with a different outcome is
involved would repay further study.
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